Mirae Asset Global Investments’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.9K Buy
3,306
+480
+17% +$1.73K ﹤0.01% 1468
2025
Q1
$8.28K Buy
2,826
+11
+0.4% +$32 ﹤0.01% 1487
2024
Q4
$9.37K Sell
2,815
-238
-8% -$793 ﹤0.01% 1519
2024
Q3
$10.5K Buy
3,053
+538
+21% +$1.85K ﹤0.01% 1494
2024
Q2
$8.5K Sell
2,515
-27,950
-92% -$94.5K ﹤0.01% 1470
2024
Q1
$97.3K Buy
+30,465
New +$97.3K ﹤0.01% 2373
2023
Q4
Sell
-29,926
Closed -$89.8K 2531
2023
Q3
$89.8K Buy
29,926
+73
+0.2% +$219 ﹤0.01% 2483
2023
Q2
$112K Sell
29,853
-170
-0.6% -$636 ﹤0.01% 2480
2023
Q1
$101K Sell
30,023
-52
-0.2% -$174 ﹤0.01% 2445
2022
Q4
$145K Buy
30,075
+30
+0.1% +$144 ﹤0.01% 2380
2022
Q3
$171K Buy
30,045
+9,644
+47% +$54.9K ﹤0.01% 2386
2022
Q2
$145K Buy
+20,401
New +$145K ﹤0.01% 2240